Question 1

What is Bioventus Inc. Class A Common Stock's WACC?

Accepted Answer

Bioventus Inc. Class A Common Stock (BVS) has a Weighted Average Cost of Capital (WACC) of 7.54%. This is calculated using a Cost of Equity of 9.36% (via CAPM with a beta of 1.16) and a pre-tax Cost of Debt of 2.00%, with an equity weight of 76.63% in the capital structure.

Question 2

Is Bioventus Inc. Class A Common Stock's WACC high or low?

Accepted Answer

Bioventus Inc. Class A Common Stock's WACC of 7.54% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Bioventus Inc. Class A Common Stock's WACC calculated?

Accepted Answer

Bioventus Inc. Class A Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 9.36% is derived from the CAPM model using a beta of 1.16. The pre-tax Cost of Debt (Rd) is 2.00%. The capital structure is 76.63% equity and 23.37% debt.

Bioventus Inc. Class A Common Stock (BVS) — WACC 分析

WACC 构成

解读

Bioventus Inc. Class A Common Stock（BVS）WACC：7.54%

WACC计算器

Bioventus Inc. Class A Common Stock（BVS） WACC 解读

BVS 公司分析

BVS DCF 估值

继续做同行对比